bi 671800
Small moleculeexperimental
Clinical trial activity
9 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2009 (NCT01007721)
Timeline
Indications
Mechanism of action
- Prostanoid DP receptorANTAGONIST
PTGDR antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bi671800
- bi 671800
- bi 671800
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01216384 | Phase 1 | Oct 1, 2010 | Boehringer Ingelheim |
| NCT01215773 | Phase 1 | Oct 1, 2010 | Boehringer Ingelheim |
| NCT01205373 | Phase 1 | Sep 1, 2010 | Boehringer Ingelheim |
| NCT01103349 | Phase 2 | Mar 1, 2010 | Boehringer Ingelheim |
| NCT01090024 | Phase 2 | Mar 1, 2010 | Boehringer Ingelheim |
| NCT01092143 | Phase 2 | Mar 1, 2010 | Boehringer Ingelheim |
| NCT02221388 | Phase 1 | Feb 1, 2010 | Boehringer Ingelheim |
| NCT02222233 | Phase 1 | Jan 1, 2010 | Boehringer Ingelheim |
| NCT01007721 | Phase 2 | Oct 1, 2009 | Boehringer Ingelheim |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 9 | 9 | 2 | 2009 |
1 organizations
Page 1 / 1